Can I read Bluebird Bio: Gene Therapy Insights on EtoBox?

Bluebird Bio: Gene Therapy Insights by ng28 is a document available to read on EtoBox.

What is Bluebird Bio: Gene Therapy Insights about?

- Bluebird Bio is a clinical-stage biotechnology company focused on developing gene therapies for severe genetic diseases and cancer. - Its lead product candidates include Zynteglo for transfusion-dependent beta-thalassemia, Lenti-D for cerebral adrenoleukodystrophy (CALD), and LentiGlobin for sickle cell disease. - If approved, Zynteglo has the potential to be the first gene therapy approved for transfusion-dependent beta-thalassemia and could generate over $1 billion in annual revenue.

Author

ng28

Language

EN